Pain and inflammation, TraumatologyRx (Retseptli)

Aviten 20

Dosage form:Lyophilized powder for preparation of injection solution 20 mg complete with solvent - water for injection 2 ml + 2 ml
Category:Pain and inflammation, Traumatology

Indications for Use

Inflammatory-degenerative diseases of the musculoskeletal system with pain syndrome: rheumatoid arthritis, gouty arthritis, ankylosing spondylitis, non-specific infectious polyarthritis, osteoarthrosis, osteochondrosis, tendinitis, bursitis, myositis, periarthritis, arthralgia, neuralgia, myalgia, sciatica, lumbago, injuries, sprains, dislocations, and other soft tissue damage.

Composition & Active Ingredient

Active Ingredient: Active ingredient information will be updated according to the official instruction.
Composition: Each vial contains: active substance — tenoxicam 20 mg; excipients — mannitol, ascorbic acid, disodium edetate, sodium metabisulfite, sodium hydroxide (pellets), trometamol (Tris), water for injections. 1 ampoule of solvent contains: sterile water for injections — 2.0 mL.

Dosage & Administration

Dosage: Administered intramuscularly or intravenously. Dissolve the lyophilizate in 2 mL of the supplied solvent. Acute gout attacks: IV or IM 20 mg once or twice daily for 2–3 days, then switch to oral form 20 mg once daily for 5 days. Rheumatoid arthritis: IV or IM 20 mg once daily for 2 days, then oral form 20 mg once daily for one month. Pain syndrome: IV or IM 20–40 mg once daily until pain resolves. Treatment duration for acute musculoskeletal conditions is usually up to 7 days (up to 14 days in severe cases). Use the lowest effective dose with caution in elderly patients.
Usage Instructions: For intramuscular or intravenous administration. The reconstituted solution must be used immediately after dissolution.

Contraindications

Hypersensitivity to tenoxicam or excipients, and to other NSAIDs (including ibuprofen and aspirin); active peptic ulcer/bleeding or history of recurrent ulcer; ulcerative colitis; Crohn's disease; severe gastritis; history of GI bleeding or perforation related to prior NSAID therapy; severe cardiac, hepatic, or renal failure; blood disorders; glucose-6-phosphate dehydrogenase deficiency; third trimester of pregnancy.

Storage & Packaging

Storage Conditions: Store in a dry place protected from light, at a temperature not exceeding 30°C. Keep out of reach of children. Shelf life of the lyophilized powder — 2 years; solvent (water for injection) — 3 years.
Package Description: Dosage form and package: Lyophilized powder for preparation of injection solution 20 mg complete with solvent - water for injection 2 ml + 2 ml
PDF

Official Medical Leaflet

Approved PDF Document • Complete Prescribing Info

Open Medical Leaflet (PDF)

Medical Disclaimer: All information provided on this website is for educational purposes only and does not substitute professional medical advice. Consult a healthcare professional and read the official packaging insert before use.

Related Products